An extended Bayesian semi-mechanistic dose-finding design for phase I oncology trials using pharmacokinetic and pharmacodynamic information

Cites Work

Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
Inference from iterative simulation using multiple sequences
Accelerating MCMC via Kriging-based adaptive independent proposals and delayed rejection
Dynamic calibration of pharmacokinetic parameters in dose-finding studies
Easy-to-implement Bayesian methods for dose-escalation studies in healthy volunteers
Dose‐finding methods for Phase I clinical trials using pharmacokinetics in small populations
Bayesian dose regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics
Using simulation studies to evaluate statistical methods
Bayesian modeling of a bivariate toxicity outcome for early phase oncology trials evaluating dose regimens
A Bayesian time-to-event pharmacokinetic model for phase I dose-escalation trials with multiple schedules

This page was built for publication: An extended Bayesian semi-mechanistic dose-finding design for phase I oncology trials using pharmacokinetic and pharmacodynamic information